CMS Measure ID: #490 Collection Type: CQM Reporting Frequency: Once per episode of treatment Outcome: No High Priority: No NQS Domain: Effective Clinical CareContinue reading “2023 # 490 Appropriate Intervention of Immune-Related Diarrhea and/or Colitis in Patients Treated with Immune Checkpoint Inhibitors”
CQM Archive
2023 # 491 Mismatch Repair (MMR) or Microsatellite Instability (MSI) Biomarker Testing Status in Colorectal Carcinoma, Endometrial, Gastroesophageal, or Small Bowel Carcinoma
CMS Measure ID: #491 Collection Type: CQM Reporting Frequency: Every visit Outcome: No High Priority: No NQS Domain: Effective Clinical Care Measure Age: NewContinue reading “2023 # 491 Mismatch Repair (MMR) or Microsatellite Instability (MSI) Biomarker Testing Status in Colorectal Carcinoma, Endometrial, Gastroesophageal, or Small Bowel Carcinoma”
2023 # 493 Adult Immunization Status
CMS Measure ID: #493 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: No NQS Domain: Effective Clinical CareContinue reading “2023 # 493 Adult Immunization Status”
2023 # 450 Appropriate Treatment for Patients with Stage I (T1c) – III HER2 Positive Breast Cancer
CMS Measure ID: #450 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: Yes NQS Domain: Effective Clinical CareContinue reading “2023 # 450 Appropriate Treatment for Patients with Stage I (T1c) – III HER2 Positive Breast Cancer”
2023 # 451 RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy
CMS Measure ID: #451 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: No NQS Domain: Effective Clinical CareContinue reading “2023 # 451 RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy”
2023 # 452 Patients with Metastatic Colorectal Cancer and RAS (KRAS or NRAS) Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies
CMS Measure ID: #452 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: Yes NQS Domain: Patient Safety MeasureContinue reading “2023 # 452 Patients with Metastatic Colorectal Cancer and RAS (KRAS or NRAS) Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies”
2023 # 453 Percentage of Patients Who Died from Cancer Receiving Systemic Cancer-Directed Therapy in the Last 14 Days of Life (lower score – better)
CMS Measure ID: #453 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: Yes NQS Domain: Effective Clinical CareContinue reading “2023 # 453 Percentage of Patients Who Died from Cancer Receiving Systemic Cancer-Directed Therapy in the Last 14 Days of Life (lower score – better)”
2023 # 457 Percentage of Patients Who Died from Cancer Admitted to Hospice for Less than 3 days (lower score – better)
CMS Measure ID: #457 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: Yes High Priority: Yes NQS Domain: Effective Clinical CareContinue reading “2023 # 457 Percentage of Patients Who Died from Cancer Admitted to Hospice for Less than 3 days (lower score – better)”
2023 # 459 Back Pain After Lumbar Surgery
CMS Measure ID: #459 Collection Type: CQM Reporting Frequency: Every visit Outcome: Yes High Priority: Yes NQS Domain: Person and Caregiver-Centered Experience Outcomes MeasureContinue reading “2023 # 459 Back Pain After Lumbar Surgery”
2023 # 461 Leg Pain After Lumbar Surgery
CMS Measure ID: #461 Collection Type: CQM Reporting Frequency: Every visit Outcome: Yes High Priority: Yes NQS Domain: Person and Caregiver-Centered Experience Outcomes MeasureContinue reading “2023 # 461 Leg Pain After Lumbar Surgery”